{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:02:55Z","timestamp":1784851375731,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"DOI":"10.1038\/s41389-026-00631-3","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:44:10Z","timestamp":1779885850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The central precocious puberty-associated gene MKRN3 is a tumor suppressor regulating CSDE1 ubiquitination in ovarian cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Fengrui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-7546","authenticated-orcid":false,"given":"Simin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3229-5467","authenticated-orcid":false,"given":"Yuexiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2961-3770","authenticated-orcid":false,"given":"Yuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"631_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"631_CR2","first-page":"280","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69:280\u2013304.","journal-title":"CA Cancer J Clin"},{"key":"631_CR3","doi-asserted-by":"publisher","first-page":"viii51","DOI":"10.1093\/annonc\/mdx441","volume":"28","author":"S Pignata","year":"2017","unstructured":"Pignata S, Cecere SC, Du Bois A, Harter P, Heitz F. Treatment of recurrent ovarian cancer. Ann Oncol. 2017;28:viii51\u20136.","journal-title":"Ann Oncol"},{"key":"631_CR4","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","volume":"385","author":"P Harter","year":"2021","unstructured":"Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, Meier W, et al. Randomized trial of cytoreductive surgery for relapsed ovarian cancer. N Engl J Med. 2021;385:2123\u201331.","journal-title":"N Engl J Med"},{"key":"631_CR5","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1002\/ijc.27952","volume":"132","author":"TT Gong","year":"2013","unstructured":"Gong TT, Wu QJ, Vogtmann E, Lin B, Wang YL. Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies. Int J Cancer. 2013;132:2894\u2013900.","journal-title":"Int J Cancer"},{"key":"631_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21:389\u2013400.","journal-title":"Nat Rev Clin Oncol"},{"key":"631_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/ng.3841","volume":"49","author":"FR Day","year":"2017","unstructured":"Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet. 2017;49:834\u201341.","journal-title":"Nat Genet"},{"key":"631_CR8","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1302160","volume":"368","author":"AP Abreu","year":"2013","unstructured":"Abreu AP, et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013;368:2467\u201375.","journal-title":"N Engl J Med"},{"key":"631_CR9","doi-asserted-by":"publisher","first-page":"e20210151","DOI":"10.1084\/jem.20210151","volume":"218","author":"K Li","year":"2021","unstructured":"Li K, Zheng X, Tang H, Zang YS, Zeng C, Liu X. et al. E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer. J Exp Med. 2021;218:e20210151","journal-title":"J Exp Med"},{"key":"631_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jpag.2008.10.003","volume":"22","author":"F Bas","year":"2009","unstructured":"Bas F, Pescovitz OH, Steinmetz R. No activating mutations of FSH receptor in four children with ovarian juvenile granulosa cell tumors and the association of these tumors with central precocious puberty. J Pediatr Adolesc Gynecol. 2009;22:173\u20139.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"631_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jpag.2017.01.011","volume":"30","author":"BK Aydin","year":"2017","unstructured":"Aydin BK, Saka N, Bas F, Yilmaz Y, Haliloglu B, Guran T, et al. Evaluation and treatment results of ovarian cysts in childhood and adolescence: a multicenter, retrospective study of 100 patients. J Pediatr Adolesc Gynecol. 2017;30:449\u201355.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"631_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nrendo.2017.63","volume":"13","author":"D Holmes","year":"2017","unstructured":"Holmes D. Reproductive endocrinology: puberty timing and cancer risk. Nat Rev Endocrinol. 2017;13:377.","journal-title":"Nat Rev Endocrinol"},{"key":"631_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/humupd\/dmm012","volume":"13","author":"CM Greiser","year":"2007","unstructured":"Greiser CM, Greiser EM, D\u00f6ren M. Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. Hum Reprod Update. 2007;13:453\u201363.","journal-title":"Hum Reprod Update"},{"key":"631_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jama.288.3.368","volume":"288","author":"KL Noller","year":"2002","unstructured":"Noller KL. Estrogen replacement therapy and risk of ovarian cancer. Jama. 2002;288:368\u20139.","journal-title":"Jama"},{"key":"631_CR15","doi-asserted-by":"publisher","first-page":"e164178","DOI":"10.1172\/jci.insight.164178","volume":"8","author":"L Naul\u00e9","year":"2023","unstructured":"Naul\u00e9 L, Mancini A, Pereira SA, Gassaway BM, Lydeard JR, Magnotto JC. et al. MKRN3 inhibits puberty onset via interaction with IGF2BP1 and regulation of hypothalamic plasticity. JCI Insight. 2023;8:e164178","journal-title":"JCI Insight"},{"key":"631_CR16","first-page":"1558","volume":"89","author":"EA Guseva","year":"2024","unstructured":"Guseva EA, Emelianova MA, Sidorova VN, Tyulpakov AN, Dontsova OA, Sergiev PV. Diversity of molecular functions of RNA-binding ubiquitin ligases from the MKRN protein family. Biochemistry. 2024;89:1558\u201372.","journal-title":"Biochemistry"},{"key":"631_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/PGP.0000000000000207","volume":"35","author":"R Vang","year":"2016","unstructured":"Vang R, Levine DA, Soslow RA, Zaloudek C, Shih IM, Kurman RJ. Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: a rereview of cases lacking TP53 mutations in the cancer genome atlas ovarian study. Int J Gynecol Pathol. 2016;35:48\u201355.","journal-title":"Int J Gynecol Pathol"},{"key":"631_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1158\/2159-8290.CD-20-0455","volume":"11","author":"S Zhang","year":"2021","unstructured":"Zhang S, Iyer S, Ran H, Dolgalev I, Gu S, Wei W, et al. Genetically defined, syngeneic organoid platform for developing combination therapies for ovarian. Cancer Cancer Discov. 2021;11:362\u201383.","journal-title":"Cancer Cancer Discov"},{"key":"631_CR19","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/cas.14414","volume":"111","author":"S Umemura","year":"2020","unstructured":"Umemura S, Sowa Y, Iizumi Y, Kitawaki J, Sakai T. Synergistic effect of the inhibitors of RAF\/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression. Cancer Sci. 2020;111:2052\u201361.","journal-title":"Cancer Sci"},{"key":"631_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0496-2","volume":"18","author":"AX Guo","year":"2020","unstructured":"Guo AX, Cui JJ, Wang LY, Yin JY. The role of CSDE1 in translational reprogramming and human diseases. Cell Commun Signal. 2020;18. 14.","journal-title":"Cell Commun Signal"},{"key":"631_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-837","volume":"14","author":"Z P\u00e9nzv\u00e1lt\u00f3","year":"2014","unstructured":"P\u00e9nzv\u00e1lt\u00f3 Z, L\u00e1nczky A, L\u00e9n\u00e1rt J, Meggyesh\u00e1zi N, Kren\u00e1cs T, Szoboszlai N, et al. MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer. BMC Cancer. 2014;14. 837.","journal-title":"BMC Cancer"},{"key":"631_CR22","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393:1240\u201353.","journal-title":"Lancet"},{"key":"631_CR23","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM, et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA. 2011;108:18032\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"631_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/cells11030539","volume":"11","author":"D Samuel","year":"2022","unstructured":"Samuel D, Diaz-Barbe A, Pinto A, Schlumbrecht M, George S. Hereditary ovarian carcinoma: cancer pathogenesis looking beyond BRCA1 and BRCA2. Cells. 2022;11:539","journal-title":"Cells"},{"key":"631_CR25","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","volume":"4","author":"PA Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer. 2023;4:1239\u201357.","journal-title":"Nat Cancer"},{"key":"631_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tcb.2015.03.002","volume":"25","author":"MJ Clague","year":"2015","unstructured":"Clague MJ, Heride C, Urb\u00e9 S. The demographics of the ubiquitin system. Trends Cell Biol. 2015;25:417\u201326. p.","journal-title":"Trends Cell Biol"},{"key":"631_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28:591\u2013605.","journal-title":"Cell Death Differ"},{"key":"631_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23. 148.","journal-title":"Mol Cancer"},{"key":"631_CR29","first-page":"284","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284\u201396.","journal-title":"CA Cancer J Clin"},{"key":"631_CR30","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397:2182\u201393.","journal-title":"Lancet"},{"key":"631_CR31","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1200\/JCO.19.02960","volume":"38","author":"PA Konstantinopoulos","year":"2020","unstructured":"Konstantinopoulos PA, Norquist B, Lacchetti C, Armstrong D, Grisham RN, Goodfellow PJ, et al. Germline and somatic tumor testing in epithelial ovarian cancer: ASCO Guideline. J Clin Oncol. 2020;38:1222\u201345.","journal-title":"J Clin Oncol"},{"key":"631_CR32","doi-asserted-by":"publisher","first-page":"1172565","DOI":"10.3389\/fmed.2023.1172565","volume":"10","author":"C Maya-Gonz\u00e1lez","year":"2023","unstructured":"Maya-Gonz\u00e1lez C, Wessman S, Lagerstedt-Robinson K, Taylan F, Tesi B, Kuchinskaya E, et al. Register-based and genetic studies of Prader-Willi syndrome show a high frequency of gonadal tumors and a possible mechanism for tumorigenesis through imprinting relaxation. Front Med. 2023;10:1172565.","journal-title":"Front Med"},{"key":"631_CR33","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S2352-4642(23)00237-7","volume":"7","author":"EL Zevin","year":"2023","unstructured":"Zevin EL, Eugster EA. Central precocious puberty: a review of diagnosis, treatment, and outcomes. Lancet Child Adolesc Health. 2023;7:886\u201396.","journal-title":"Lancet Child Adolesc Health"},{"key":"631_CR34","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.3390\/cancers13174412","volume":"13","author":"B Bosco","year":"2021","unstructured":"Bosco B, Rossi A, Rizzotto D, Hamadou MH, Bisio A, Giorgetta S. et al. DHX30 coordinates cytoplasmic translation and mitochondrial function contributing to cancer cell survival. Cancers. 2021;13:4412","journal-title":"Cancers"},{"key":"631_CR35","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1146\/annurev.biochem.68.1.913","volume":"68","author":"AC Gingras","year":"1999","unstructured":"Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem. 1999;68:913\u201363.","journal-title":"Annu Rev Biochem"},{"key":"631_CR36","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s10147-010-0172-4","volume":"16","author":"K Gezgin\u00e7","year":"2011","unstructured":"Gezgin\u00e7 K, Yazici F, Tavli L. Uterine smooth muscle tumors of uncertain malignant potential: a case presentation. Int J Clin Oncol. 2011;16:592\u20135.","journal-title":"Int J Clin Oncol"},{"key":"631_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 Tumors from 33 types of cancer. Cell. 2018;173:291\u2013304.e6.","journal-title":"Cell"},{"key":"631_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"631_CR39","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"631_CR40","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE biopharma collaborative in cBioPortal. Cancer Res. 2023;83:3861\u20137.","journal-title":"Cancer Res"},{"key":"631_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nm1173","volume":"11","author":"DM Dinulescu","year":"2005","unstructured":"Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med. 2005;11:63\u201370.","journal-title":"Nat Med"},{"key":"631_CR42","doi-asserted-by":"publisher","first-page":"101164","DOI":"10.1016\/j.xpro.2022.101164","volume":"3","author":"MJ Ford","year":"2022","unstructured":"Ford MJ, Harwalkar K, Yamanaka Y. Protocol to generate mouse oviduct epithelial organoids for viral transduction and whole-mount 3D imaging. STAR Protoc. 2022;3:101164.","journal-title":"STAR Protoc"},{"key":"631_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1126\/science.1124619","volume":"312","author":"B Domon","year":"2006","unstructured":"Domon B, Aebersold R. Mass spectrometry and protein analysis. Science. 2006;312:212\u20137.","journal-title":"Science"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00631-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00631-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00631-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:47:16Z","timestamp":1784850436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-026-00631-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1038\/s41389-026-00631-3","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The study was approved by the Institutional Review Board of Obstetrics and Gynecology Hospital of Fudan University (approval no. 2024-168). Informed written consent was obtained from all human participants. The animal experiments were approved by Institutional Animal Care and Use Committee of the Shanghai Institute of Nutrition and Health Chinese Academy of Science (with approved ID SIBS-2023-WYX-1).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"40"}}